Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
Quarterly results
BiomX Inc. (PHGE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
05/15/2023 8-K Quarterly results
Docs: "BiomX Reports First Quarter 2023 Financial Results and Provides Business Update"
11/09/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
03/30/2022 8-K Quarterly results
Docs: "CONSOLIDATED STATEMENTS OF OPERATIONS",
"INVESTOR PRESENTATION DATED MARCH 30, 2022"
11/15/2021 8-K Quarterly results
Docs: "BiomX Reports Third Quarter 2021 Financial Results and Provides Business Update",
"INVESTOR PRESENTATION DATED NOVEMBER 15, 2021"
08/16/2021 8-K Quarterly results
03/31/2021 8-K Quarterly results
11/12/2020 8-K Quarterly results
Docs: "About the BOLT Platform The newly unveiled BOLT R&D platform enables BiomX to rapidly develop, manufacture and formulate a phage treatment targeting a given pathogenic bacteria. The platform allows BiomX to conduct an initial clinical proof of concept study in patients within approximately 12-18 months of project initiation 1 . The ability to move quickly into clinical development is also driven by the strong safety profile of naturally-occurring phage, as corroborated by regulatory guidance provided to BiomX by the FDA as relating to its IBD program, allowing the Company to bypass safety studies and studies in healthy volunteers and to proceed directly to patient studies. 1 In certain indications the length of clinical proof of concept may be longer depending on indication, identity of ta...",
"Investor Presentation"
08/13/2020 8-K Quarterly results
05/14/2020 8-K Investor presentation, Quarterly results
Docs: "Ness Ziona, Israel – May 14, 2020 – BiomX Inc. , a clinical-stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, today reported financial results and provided a business update for the first quarter ended March 31, 2020.",
"Investor Presentation"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy